Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 825

1.

Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial.

Hopewell S, Boutron I, Altman DG, Barbour G, Moher D, Montori V, Schriger D, Cook J, Gerry S, Omar O, Dutton P, Roberts C, Frangou E, Clifton L, Chiocchia V, Rombach I, Wartolowska K, Ravaud P.

BMC Med. 2016 Nov 28;14(1):199.

2.

No rationale for 1 variable per 10 events criterion for binary logistic regression analysis.

van Smeden M, de Groot JA, Moons KG, Collins GS, Altman DG, Eijkemans MJ, Reitsma JB.

BMC Med Res Methodol. 2016 Nov 24;16(1):163.

3.

International standards for symphysis-fundal height based on serial measurements from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: prospective cohort study in eight countries.

Papageorghiou AT, Ohuma EO, Gravett MG, Hirst J, da Silveira MF, Lambert A, Carvalho M, Jaffer YA, Altman DG, Noble JA, Bertino E, Purwar M, Pang R, Cheikh Ismail L, Victora C, Bhutta ZA, Kennedy SH, Villar J; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st)..

BMJ. 2016 Nov 7;355:i5662. doi: 10.1136/bmj.i5662.

4.

International Estimated Fetal Weight Standards of the INTERGROWTH-21st Project.

Stirnemann J, Villar J, Salomon LJ, Ohuma E, Ruyan P, Altman DG, Nosten F, Craik R, Munim S, Cheikh Ismail L, Barros FC, Lambert A, Norris S, Carvalho M, Jaffer YA, Noble JA, Bertino E, Gravett MG, Purwar M, Victora C, Uauy R, Bhutta Z, Kennedy S, Papageorghiou AT; for the International Fetal Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st)..

Ultrasound Obstet Gynecol. 2016 Nov 2. doi: 10.1002/uog.17347. [Epub ahead of print]

PMID:
27804212
5.

Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment.

Nagendran M, Pereira TV, Kiew G, Altman DG, Maruthappu M, Ioannidis JP, McCulloch P.

BMJ. 2016 Oct 27;355:i5432. doi: 10.1136/bmj.i5432.

6.

Core Outcome Set-STAndards for Reporting: The COS-STAR Statement.

Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Moher D, Schmitt J, Tugwell P, Tunis S, Williamson PR.

PLoS Med. 2016 Oct 18;13(10):e1002148. doi: 10.1371/journal.pmed.1002148.

7.

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP.

BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919. No abstract available.

8.

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.

Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA.

BMJ. 2016 Sep 6;354:i4482. doi: 10.1136/bmj.i4482.

9.

Systematic review of the methodological and reporting quality of case series in surgery.

Agha RA, Fowler AJ, Lee SY, Gundogan B, Whitehurst K, Sagoo HK, Jeong KJ, Altman DG, Orgill DP.

Br J Surg. 2016 Sep;103(10):1253-8. doi: 10.1002/bjs.10235. Review.

PMID:
27511619
10.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krle A-Jerić K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D.

Rev Panam Salud Publica. 2015 Dec;38(6):506-14.

11.

Moderate Alcohol Intake and Cardiometabolic Risk in Adults With Type 2 Diabetes.

Altman DG.

Ann Intern Med. 2016 Jul 5;165(1):67-8. doi: 10.7326/L16-5013. No abstract available.

PMID:
27380289
12.

Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.

Kent DM, Nelson J, Dahabreh IJ, Rothwell PM, Altman DG, Hayward RA.

Int J Epidemiol. 2016 Jul 3. pii: dyw118. [Epub ahead of print]

PMID:
27375287
13.

Update on the endorsement of CONSORT by high impact factor journals: a survey of journal "Instructions to Authors" in 2014.

Shamseer L, Hopewell S, Altman DG, Moher D, Schulz KF.

Trials. 2016 Jun 24;17(1):301. doi: 10.1186/s13063-016-1408-z.

14.

External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges.

Riley RD, Ensor J, Snell KI, Debray TP, Altman DG, Moons KG, Collins GS.

BMJ. 2016 Jun 22;353:i3140. doi: 10.1136/bmj.i3140. No abstract available.

15.

AKI and Long-Term Risk for Cardiovascular Events and Mortality.

Odutayo A, Wong CX, Farkouh M, Altman DG, Hopewell S, Emdin CA, Hunn BH.

J Am Soc Nephrol. 2016 Jun 13. pii: ASN.2016010105. [Epub ahead of print]

PMID:
27297949
16.

Authors' reply to Cunningham and Messerli and colleagues.

Kotecha D, Altman DG, Collins PD, Flather MD.

BMJ. 2016 Jun 7;353:i3141. doi: 10.1136/bmj.i3141. No abstract available.

PMID:
27268202
17.

Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study.

Page MJ, Shamseer L, Altman DG, Tetzlaff J, Sampson M, Tricco AC, Catalá-López F, Li L, Reid EK, Sarkis-Onofre R, Moher D.

PLoS Med. 2016 May 24;13(5):e1002028. doi: 10.1371/journal.pmed.1002028.

18.

Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.

Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG.

Eur J Epidemiol. 2016 Apr;31(4):337-50. doi: 10.1007/s10654-016-0149-3.

19.

Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model.

Collins GS, Ogundimu EO, Cook JA, Manach YL, Altman DG.

Stat Med. 2016 Oct 15;35(23):4124-35. doi: 10.1002/sim.6986.

20.

Peer reviewers identified spin in manuscripts of nonrandomized studies assessing therapeutic interventions, but their impact on spin in abstract conclusions was limited.

Lazarus C, Haneef R, Ravaud P, Hopewell S, Altman DG, Boutron I.

J Clin Epidemiol. 2016 Sep;77:44-51. doi: 10.1016/j.jclinepi.2016.04.012.

PMID:
27164274
Items per page

Supplemental Content

Loading ...
Support Center